MedPath

Levothyroxine Sodium

Levothyroxine Sodium

Approved
Approval ID

7a5a9e87-383a-4450-bf79-1f4f68655ace

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 22, 2015

Manufacturers
FDA

Northwind Pharmaceuticals

DUNS: 036986393

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levothyroxine Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51655-295
Application NumberNDA021342
Product Classification
M
Marketing Category
C73594
G
Generic Name
Levothyroxine Sodium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 23, 2015
FDA Product Classification

INGREDIENTS (1)

LEVOTHYROXINE SODIUMActive
Quantity: 0.1 mg in 1 1
Code: 9J765S329G
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levothyroxine Sodium - FDA Drug Approval Details